Resmed (RMD) Other Non-Current Assets (2010 - 2026)

Resmed has reported Other Non-Current Assets for 17 years, with the latest figure at $210.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 20.67% year-over-year to $210.7 million; the trailing twelve-month figure through Mar 2026 stood at $210.7 million (up 20.67% YoY), and the FY2025 full-year result was $185.8 million, down 34.56% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $210.7 million, up from $193.9 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $284.0 million in Q2 2024, with the low at $169.4 million in Q1 2022.
• Historically, Other Non-Current Assets has averaged $225.0 million across 5 years, with a median of $210.7 million in 2026.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets surged 7336.92% — and 2025, when it tumbled 37.03%.
• Resmed's Other Non-Current Assets stood at $260.2 million in 2022, then rose by 6.02% to $275.8 million in 2023, then tumbled by 34.31% to $181.2 million in 2024, then grew by 7.01% to $193.9 million in 2025, then increased by 8.69% to $210.7 million in 2026.
• The last three Other Non-Current Assets figures came in at $210.7 million (Q1 2026), $193.9 million (Q4 2025), and $189.8 million (Q3 2025), per Business Quant data.